Hepatic transit time: indicator of the therapeutic response to radiofrequency ablation of liver tumours. The aim of this study was to evaluate changes of hepatic transit time (HTT) in patients treated by radiofrequency ablation (RFA). Five consecutive patients (2 females, 3 males mean age 66 years) referred for treatment of liver neoplasm with percutaneous application of RFA were included in this study. The HTT of contrast agent (Sonovue(R)